Product Code: TMRGL85234
TMR's report on the global healthcare contract development and manufacturing organization market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global healthcare contract development and manufacturing organization market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global healthcare contract development and manufacturing organization market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the healthcare contract development and manufacturing organization market.
The report delves into the competitive landscape of the global healthcare contract development and manufacturing organization market. Key players operating in the global healthcare contract development and manufacturing organization market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global healthcare contract development and manufacturing organization market profiled in this report.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Summary of Statistics
- 1.3. Key Market Characteristics & Attributes
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
- 3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Healthcare Contract Development And Manufacturing Organization Demand
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Mn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
- 3.2. Key Trends Impacting the Market
- 3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
- 4.1. Global Healthcare Contract Development And Manufacturing Organization Market (US$ Mn)
- 4.2. Healthcare Contract Development And Manufacturing Organization Market Opportunity Assessment (US$ Mn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
- 4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
- 4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
- 4.4.1.1. In Short Term
- 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
- 4.4.2.1. In Short Term
- 4.4.2.2. In Long Term
- 4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Global Healthcare Contract Development And Manufacturing Organization Market Growth
- 4.5.3. Healthcare Contract Development And Manufacturing Organization Adoption Rate, by Country
- 4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Healthcare Contract Development And Manufacturing Organization Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
- 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
- 5.2. Banking on with Segments High Incremental Opportunity
- 5.3. Peer Benchmarking
6. Global Healthcare Contract Development And Manufacturing Organization Market Demand Analysis 2017-2021 and Forecast, 2022-2032
- 6.1. Historical Market Analysis, 2017-2021
- 6.2. Current and Future Market Projections, 2022-2032
- 6.3. Y-o-Y Growth Trend Analysis
7. Global Healthcare Contract Development And Manufacturing Organization Market Value Analysis 2017-2021 and Forecast, 2022-2032
- 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
- 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032, By Services
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Services , 2017-2021
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Services , 2022-2032
- 8.3.1. Contract Development
- 8.3.1.1. Small Molecule
- 8.3.1.2. Large Molecule
- 8.3.1.3. Shockwave Therapy
- 8.3.2. Contract Manufacturing
- 8.3.2.1. Small Molecule
- 8.3.2.2. Large Molecule
- 8.3.2.3. High Potency API
- 8.3.2.4. Finished Dose Formulations
- 8.3.2.5. Medical Devices
- 8.4. Market Attractiveness Analysis By Services
9. Global Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 9.1. Introduction
- 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
- 9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
- 9.3.1. North America
- 9.3.2. Latin America
- 9.3.3. Europe
- 9.3.4. Asia Pacific
- 9.3.5. Middle East and Africa (MEA)
- 9.4. Market Attractiveness Analysis By Region
10. North America Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032
- 10.1. Introduction
- 10.2. Pricing Analysis
- 10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 10.4.1. By Country
- 10.4.1.1. U.S.
- 10.4.1.2. Canada
- 10.4.2. By Services
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Country
- 10.5.2. By Services
11. Latin America Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032
- 11.1. Introduction
- 11.2. Pricing Analysis
- 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 11.4.1. By Country
- 11.4.1.1. Brazil
- 11.4.1.2. Mexico
- 11.4.1.3. Rest of Latin America
- 11.4.2. By Services
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Services
12. Europe Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032
- 12.1. Introduction
- 12.2. Pricing Analysis
- 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 12.4.1. By Country
- 12.4.1.1. Germany
- 12.4.1.2. France
- 12.4.1.3. U.K.
- 12.4.1.4. Italy
- 12.4.1.5. Benelux
- 12.4.1.6. Nordic Countries
- 12.4.1.7. Rest of Europe
- 12.4.2. By Services
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Services
13. Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032
- 13.1. Introduction
- 13.2. Pricing Analysis
- 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 13.4.1. By Country
- 13.4.1.1. China
- 13.4.1.2. Japan
- 13.4.1.3. South Korea
- 13.4.1.4. Rest of Asia Pacific
- 13.4.2. By Services
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Services
14. Middle East and Africa Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032
- 14.1. Introduction
- 14.2. Pricing Analysis
- 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 14.4.1. By Country
- 14.4.1.1. GCC Countries
- 14.4.1.2. South Africa
- 14.4.1.3. Turkey
- 14.4.1.4. Rest of Middle East and Africa
- 14.4.2. By Services
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Services
15. Key Countries Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032
- 15.1. Introduction
- 15.1.1. Market Value Proportion Analysis, By Key Countries
- 15.1.2. Global Vs. Country Growth Comparison
- 15.2. US Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.2.1. Value Proportion Analysis by Market Taxonomy
- 15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.3. Canada Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.3.1. Value Proportion Analysis by Market Taxonomy
- 15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.4. Mexico Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.4.1. Value Proportion Analysis by Market Taxonomy
- 15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.5. Brazil Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.5.1. Value Proportion Analysis by Market Taxonomy
- 15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.6. Germany Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.6.1. Value Proportion Analysis by Market Taxonomy
- 15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.7. France Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.7.1. Value Proportion Analysis by Market Taxonomy
- 15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.8. Italy Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.8.1. Value Proportion Analysis by Market Taxonomy
- 15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.9. BENELUX Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.9.1. Value Proportion Analysis by Market Taxonomy
- 15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.10. UK Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.10.1. Value Proportion Analysis by Market Taxonomy
- 15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.11. Nordic Countries Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.11.1. Value Proportion Analysis by Market Taxonomy
- 15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.12. China Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.12.1. Value Proportion Analysis by Market Taxonomy
- 15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.13. Japan Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.13.1. Value Proportion Analysis by Market Taxonomy
- 15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.14. South Korea Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.14.1. Value Proportion Analysis by Market Taxonomy
- 15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.15. GCC Countries Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.15.1. Value Proportion Analysis by Market Taxonomy
- 15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.16. South Africa Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.16.1. Value Proportion Analysis by Market Taxonomy
- 15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.17. Turkey Healthcare Contract Development And Manufacturing Organization Market Analysis
- 15.17.1. Value Proportion Analysis by Market Taxonomy
- 15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
- 15.17.3. Competition Landscape and Player Concentration in the Country
16. Market Structure Analysis
- 16.1. Market Analysis by Tier of Companies
- 16.2. Market Concentration
- 16.3. Market Share Analysis of Top Players
- 16.4. Market Presence Analysis
- 16.4.1. By Regional footprint of Players
- 16.4.2. Product footprint by Players
17. Competition Analysis
- 17.1. Competition Dashboard
- 17.2. Competition Benchmarking
- 17.3. Competition Deep Dive
- 17.3.1. Catalent Inc.
- 17.3.1.1. Overview
- 17.3.1.2. Product Portfolio
- 17.3.1.3. Sales Footprint
- 17.3.1.4. Strategy Overview
- 17.3.2. Lonza Group Ltd.
- 17.3.2.1. Overview
- 17.3.2.2. Product Portfolio
- 17.3.2.3. Sales Footprint
- 17.3.2.4. Strategy Overview
- 17.3.3. Recipharm AB
- 17.3.3.1. Overview
- 17.3.3.2. Product Portfolio
- 17.3.3.3. Sales Footprint
- 17.3.3.4. Strategy Overview
- 17.3.4. Siegfried Holding AG
- 17.3.4.1. Overview
- 17.3.4.2. Product Portfolio
- 17.3.4.3. Sales Footprint
- 17.3.4.4. Strategy Overview
- 17.3.5. Thermo Fisher Scientific Inc.
- 17.3.5.1. Overview
- 17.3.5.2. Product Portfolio
- 17.3.5.3. Sales Footprint
- 17.3.5.4. Strategy Overview
- 17.3.6. Covance Inc.
- 17.3.6.1. Overview
- 17.3.6.2. Product Portfolio
- 17.3.6.3. Sales Footprint
- 17.3.6.4. Strategy Overview
- 17.3.7. Jabil
- 17.3.7.1. Overview
- 17.3.7.2. Product Portfolio
- 17.3.7.3. Sales Footprint
- 17.3.7.4. Strategy Overview
- 17.3.8. Sanmina Corporation
- 17.3.8.1. Overview
- 17.3.8.2. Product Portfolio
- 17.3.8.3. Sales Footprint
- 17.3.8.4. Strategy Overview
- 17.3.9. IQVIA Holdings Inc.
- 17.3.9.1. Overview
- 17.3.9.2. Product Portfolio
- 17.3.9.3. Sales Footprint
- 17.3.9.4. Strategy Overview
- 17.3.10. Flex
- 17.3.10.1. Overview
- 17.3.10.2. Product Portfolio
- 17.3.10.3. Sales Footprint
- 17.3.10.4. Strategy Overview
18. Assumptions and Acronyms Used
19. Research Methodology